Five Prime Therapeutics, Inc.
Pharmaceutical company · South San Francisco, California, United States
Five Prime Therapeutics, Inc. is a pharmaceutical company headquartered in South San Francisco, California, United States. It has reported private securities offerings to the US SEC, most recently $21 million sold in a notice filed in 2014.
Five Prime Therapeutics at a glance
What does Five Prime Therapeutics do?
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $21 million sold (2014).
Frequently asked questions about Five Prime Therapeutics
Where is Five Prime Therapeutics headquartered?
Five Prime Therapeutics, Inc. is headquartered in South San Francisco, California, United States.
What does Five Prime Therapeutics do?
Five Prime Therapeutics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Similar companies
- CytomX Therapeutics, Inc.South San Francisco, California, United States
- Vistagen Therapeutics, Inc.South San Francisco, California, United States
- Portola Pharmaceuticals IncSouth San Francisco, California, United States
- IDEAYA Biosciences, Inc.South San Francisco, California, United States
- Spruce Biosciences, Inc.South San Francisco, California, United States
- Meissa Vaccines IncSouth San Francisco, California, United States
- Oric Pharmaceuticals, Inc.South San Francisco, California, United States
- GigaGen, Inc.South San Francisco, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences